Status: Not yet recruiting
A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level
A multicenter, prospective, historically controlled study to evaluate the safety and effectiveness of the Triadyme-C device in comparison to other approved TDRs in the treatment of symptomatic cervical disc disease (SCDD) in subjects who are symptomatic at only a single level from C3 to C7 that are unresponsive to conservative management.
Participants needed: 164
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: DymicronUpdated: Dec 17, 2025
Eligibility criteria
Male or female subject, age ≥21. [+15]
Have an active systemic infection or infection at the operative site. [+21]